SCHEMBL3650964

SCHEMBL3650964

O=C(O)C1OCCCC1C(O)O

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.32
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3835246 0.72 MEN1 (0.38) ALDH1A1LMNASUCNR1
SCHEMBL27952996 0.71 GAA (0.35) ALDH1A1LMNAPOLBSUCNR1GAA
SCHEMBL11298204 0.71 SUCNR1 (0.43) ALDH1A1SUCNR1
SCHEMBL18964683 0.68 SUCNR1 (0.36) LMNASUCNR1
SCHEMBL19976386 0.68 SUCNR1 (0.36) LMNASUCNR1
SCHEMBL28611363 0.67 SUCNR1 (0.50) ALDH1A1LMNASUCNR1
SCHEMBL18541710 0.67
SCHEMBL19303282 0.67
SCHEMBL10357873 0.67 ALDH1A1 (0.33) ALDH1A1LMNAPOLBSUCNR1HPGD
SCHEMBL23481696 0.66 SLC1A2 (0.43) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195308-A2 ANTIINFECTIVE FLAVONONOL COMPOUNDS AND METHODS OF USE THEREOF Herbalscience Group LLC (US) 2010-06-16 EP disclosed
US-20090092624-A1 Antiinfective Flavononol Compounds and Methods of Use Thereof HERBALSCIENCE GROUP, LLC 2009-04-09 US disclosed
WO-2009026176-A2 ANTIINFECTIVE FLAVONONOL COMPOUNDS AND METHODS OF USE THEREOF HERBALSCIENCE GROUP LLC (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090092624-A1 Antiinfective Flavononol Compounds and Methods of Use Thereof MPO, VIP, FABP2 ALDH1A1 894/4885LMNA 3953/4885POLB 2990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.